F-blast is a useful marker for differentiating hypocellular refractory anemia from aplastic anemia

International Journal of Hematology

Volumn 75, Issue 3, 2002, Pages 257-260

  Jong, Weon Choi ^a,b   Fujino, Masahiko ^c   Ito, Masafumi ^a  

^a NAGOYA UNIVERSITY HOSPITAL   (Japan)

^b Inha University School of Medicine   (South Korea)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aplastic anemia; F blasts; Hypocellular refractory anemia; p53

Indexed keywords

BIOLOGICAL MARKER; HEMOGLOBIN F; PROTEIN P53;

APLASTIC ANEMIA; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; ERYTHROBLAST; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PREVALENCE; PROTEIN EXPRESSION; REFRACTORY ANEMIA; AGED; BLAST CELL CRISIS; DIFFERENTIAL DIAGNOSIS; FEMALE; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY;

AGED; ANEMIA, APLASTIC; ANEMIA, REFRACTORY; BLAST CRISIS; BONE MARROW CELLS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036546275     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02982038     Document Type: Article

References (10)

1. Boyer SH, Belding TK, Margolet L, Noyes AN. Fetal hemoglobin restriction to a few erythrocytes (F-cells) in normal human adults. Science. 1975;188:361-363.
2. Reinhardt D, Haase D, Schoch C, et al. Hemoglobin F in myelodysplastic syndrome. Ann Hematol. 1998;76:135-138.
3. Yoshida Y, Anzai N, Kawabata H. Apoptosis in myelodysplasia: a paradox or paradigm. Leuk Res. 1995;19:887-891.
4. Elghetany MT, Vyas S, Yuoh G. Significance of p53 overexpression in bone marrow biopsies from patients with bone marrow failure: aplastic anemia, hypocellular refractory anemia, and hypercellular refractory anemia. Ann Hematol. 1998;77:261-264.
5. Elghetany MT. p53 overexpression in bone marrow biopsies in refractory anemia and aplastic anemia: impact of antibody selection. Leuk Res. 2000;24:975-977.
6. Choi JW, Kim Y, Fujino M, Ito M. A new anti-hemoglobin F antibody against synthetic peptide for the detection of F-cell precursors (F-blasts) in bone marrow. Int J Hematol. 2001;74:277-280.
7. Elghetany MT, Hudnall SD, Gardner FH. Peripheral blood picture in primary hypocellular refractory anemia and idiopathic acquired aplastic anemia: an additional tool for differential diagnosis. Haematologica. 1997;82:21-24.
8. Fohlmeister I, Fischer R, Modder B, Rister M, Schaefer HE. Aplastic anemia and the hypocellular myelodysplastic syndrome. J Clin Pathol. 1985;38:1218-1224.
9. Kurotaki H, Tsushima Y, Nagai K, Yagihashi S. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia. Acta Haematol. 1999;102:115-123.
10. Kikukawa M, Aoki N, Sakamoto Y, Mori M. Study of p53 in elderly patients with myelodysplastic syndromes by immunohistochemistry and DNA analysis. Am J Pathol. 1999;155:717-721.